OBAGI-C RX system NORMAL-oily

Product NDC: 62032-534
Requested package NDC: 62032-534-04
11-digit product format: 620320534
Labeler code: 62032
Product ID: 62032-534_0388edca-7413-4eb9-8b8c-d0f6aff3ce60
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: HYDROQUINONE, HOMOSALATE, OCTISALATE AND ZINC OXIDE
Dosage form: KIT
Labeler: Obagi Cosmeceuticals LLC
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2019-12-02
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	62032-534	62032-534-04	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source date	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c5cd4727-ac49-4409-82b1-5bd8006c3ec7	Product name	1	20171122
85490a6b-2306-6bf2-c51b-eb63537dc2da	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
62032-534-04	2025-01-30	C162847	48780-1	f386c64a-338e-0266-e053-dadaa90a7c1a	OBAGI-C ® RX SYSTEM
62032-534-04	2023-02-02	C162847	48780-1	f386c64a-338e-0266-e053-dadaa90a7c1a	OBAGI-C ® RX SYSTEM
62032-534-04	2023-01-30	C162847	48780-1	f386c64a-338e-0266-e053-dadaa90a7c1a	OBAGI-C ® RX SYSTEM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
62032-534-04	OBAGI-C RX system NORMAL-oily SKIN INTERVENTION	1 in 1 KIT	KIT	1		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
62032-534	OBAGI-C RX SYSTEM NORMAL-OILY SKIN INTERVENTION (HYDROQUINONE, HOMOSALATE, OCTISALATE AND ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC]	3	Legacy NDC, 1 package rows	20230203_b31837f7-721f-484e-89d5-4ad84ad0f400.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
62032-534-04	62032053404	1 KIT in 1 KIT (62032-534-04) * 85 g in 1 TUBE * 177 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 30 mL in 1 BOTTLE, GLASS	1 kit	2019-12-02	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
OBAGI-C ® RX SYSTEM	Obagi Cosmeceuticals LLC \| G. S. Cosmeceutical USA, Inc. \| Swiss American CDMO, LLC \| Universal Packaging Systems, Inc. (DBA Paklab) \| PURETEK CORPORATION	2023-01-26	HUMAN PRESCRIPTION DRUG LABEL	3